A novel dosage form for buccal administration of bupropion

6Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Bupropion is an antidepressant used in the treatment of smoking. The purpose of this study was to prepare controlled-release hydrogel flms for buccal administration of bupropion and investigate its physicochemical and cytotoxic properties. The films were prepared from ultrapure sodium carboxymethylcellulose, hydroxypropylmethylcellulose K4M, and medium-viscosity chitosan. Evaluation of flm physicochemical characteristics was based on scanning electron microscopy, bupropion content, mechanical strength (burst strength, relaxation, resilience, and traction), and cytotoxicity. Bupropion content in bilayer flms was 121 mg per 9 cm2. The presence of bupropion modified flm mechanical strength, but did not compromise the use of this pharmaceutical form. As shown by the cytotoxicity results, flms containing bupropion did not cause cellular damage. Bupropion administration in the form of hydrogel flms is a potentially useful alternative in the treatment of smoking.

Cite

CITATION STYLE

APA

Almeida, N. M. G., Lima, R., Alves, T. F. R., De Rebelo, M. A., Severino, P., & Chaud, M. V. (2015). A novel dosage form for buccal administration of bupropion. Brazilian Journal of Pharmaceutical Sciences, 51(1), 91–100. https://doi.org/10.1590/S1984-82502015000100010

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free